DEGARELIX for Prostate cancer: Side Effects & Safety Data
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
There are 2,035 adverse event reports in the FDA FAERS database where DEGARELIX was used for Prostate cancer.
Most Reported Side Effects for DEGARELIX
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Injection site pain | 296 | 7.8% | 13 | 52 |
| Injection site erythema | 246 | 6.5% | 6 | 46 |
| Hot flush | 199 | 5.3% | 2 | 28 |
| Fatigue | 195 | 5.2% | 6 | 61 |
| Injection site swelling | 183 | 4.8% | 3 | 25 |
| Product storage error | 177 | 4.7% | 0 | 0 |
| Pyrexia | 170 | 4.5% | 8 | 96 |
| Off label use | 128 | 3.4% | 16 | 35 |
| Asthenia | 123 | 3.3% | 11 | 47 |
| Death | 120 | 3.2% | 116 | 33 |
| Injection site mass | 118 | 3.1% | 2 | 11 |
| Malaise | 117 | 3.1% | 9 | 65 |
| Fall | 113 | 3.0% | 9 | 80 |
| Prostatic specific antigen increased | 111 | 2.9% | 9 | 26 |
| Interstitial lung disease | 109 | 2.9% | 16 | 72 |
Other Indications for DEGARELIX
Product used for unknown indication (1,046)
Prostate cancer metastatic (237)
Hormone-dependent prostate cancer (187)
Hormone-refractory prostate cancer (102)
Neoplasm malignant (19)
Prostatic specific antigen increased (13)
Bone cancer (11)
Metastases to bone (11)
Prostate cancer stage iv (8)
Hormone therapy (7)
Other Drugs Used for Prostate cancer
LEUPROLIDE (45,399)
ENZALUTAMIDE (25,954)
RELUGOLIX (18,752)
ABIRATERONE (12,209)
APALUTAMIDE (3,286)
GOSERELIN (2,080)
BICALUTAMIDE (1,832)
SIPULEUCEL-T (1,720)
DENOSUMAB (1,627)
DOCETAXEL (1,551)